---
schema_version: "secwatch.filing_event.v1"
accession: "0001262463-25-000114"
form_type: "8-K"
ticker: "TWOH"
cik: "0001494413"
company_name: "Two Hands Corp"
filed_at: "2025-05-13T23:59:59+00:00"
generated_at: "2026-05-21T14:59:49.358253+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Two Hands appoints Dr. Daniel Reshef to Board of Directors

## Summary
- Dr. Daniel Reshef appointed as new Board member effective May 8, 2025.
- Board now consists of Emil Assentato, Craig Marshak, Matthew Stark, and Dr. Reshef.
- Reshef brings 25+ years in pharma at Roche, Genentech, BMS; MD, MPH, PhD from Johns Hopkins.
- Terms of Dr. Reshef's compensation still being determined.

## SEC filing metadata
- accession: 0001262463-25-000114
- form_type: 8-K
- ticker: TWOH
- cik: 0001494413
- company_name: Two Hands Corp
- filed_at: 2025-05-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1494413/000126246325000114/0001262463-25-000114-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1494413/000126246325000114/twoh8k582025.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001262463-25-000114
- JSON: https://secwatch.observer/filing/0001262463-25-000114.json
- Plain text: https://secwatch.observer/filing/0001262463-25-000114.txt

## Key facts
- Executive change
  Dr. Daniel Reshef was appointed as Director at Two Hands Corp.
  - Action: appointed
  - Role: Director
  source text: On May 8, 2025, Two Hands Corporation’s Board of Directors appointed Dr. Daniel Reshef as a member of the Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1494413/000126246325000114/0001262463-25-000114-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.